STOCK Slamf1tm1Oono Ifnar1tm1Agt/Biat

Status

Available to order

EMMA IDEM:12807
International strain nameSTOCK Slamf1tm1Oono Ifnar1tm1Agt/Biat
Alternative nameIFNAR-/- SLAM KI
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolIfnar1tm1Agt, Slamf1tm1Oono
Gene/Transgene symbolIfnar1, Slamf1

Information from provider

ProviderRoland Plesker
Provider affiliation Section 4/ZT-Central Animal husbandry, Paul-Ehrlich-Institut
Additional ownerYusuke Yanagi, M.D., Ph.D., Department of Virology, Faculty of Medicine, Kyushu University, Fukuoka, Japan
Genetic informationExon 2 encoding the V domain of mouse Slamf1 (Slam) gene replaced by human SLAM (Ohno S. et al., J Virol., 2007). Murine Ifnar1 gene targeted by germline transmission of disrupted allele (Müller U. et al., Science, 1994).
Phenotypic informationHomozygous:
IFNAR knock-out: abnormal lymphopoiesis, increased susceptibility to viral infection. SLAM knock-in: increased susceptibility of lymphocytic cells to Measles virus.

Heterozygous:
IFNAR knock-out: none SLAM knock-in: increased susceptibility of lymphocytic cells to Measles virus.
Breeding historyBred to homozygosity.
References
  • Measles virus infection of SLAM (CD150) knockin mice reproduces tropism and immunosuppression in human infection.;Ohno Shinji, Ono Nobuyuki, Seki Fumio, Takeda Makoto, Kura Shinobu, Tsuzuki Teruhisa, Yanagi Yusuke, ;2007;Journal of virology;81;1650-9; 17135325
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedyes

Information from EMMA

Archiving centreUniversity of Veterinary Medicine, Vienna, Austria
Animals used for archivinghomozygous B6.129-Slamf1tm1Oono Ifnar1tm1Agt, homozygous B6.129-Slamf1tm1Oono Ifnar1tm1Agt
Breeding at archiving centreSent animals were rederived to the SPF area (barrier) and a colony was built. This colony was used for Speed Cryo IVF and embryo freezing (slow) of double homozygous embryos.
Stage of embryos2-cell

Disease and phenotype information

IMPC phenotypes (gene matching)
  • improved glucose tolerance / IMPC
  • decreased circulating fructosamine level / IMPC
  • decreased monocyte cell number / IMPC
  • decreased KLRG1-positive NK cell number / IMPC
  • increased circulating creatinine level / IMPC
  • abnormal vibrissa morphology / IMPC
  • increased bone mineral content / IMPC
  • increased circulating amylase level / IMPC
MGI phenotypes (allele matching)
  • decreased bone mineral density / MGI
  • increased tumor growth/size / MGI
  • abnormal osteoclast morphology / MGI
  • abnormal response to infection / MGI
  • impaired natural killer cell mediated cytotoxicity / MGI
  • decreased tumor necrosis factor secretion / MGI
  • decreased interferon-alpha secretion / MGI
  • decreased interferon-beta secretion / MGI
  • decreased interleukin-6 secretion / MGI
  • increased susceptibility to bacterial infection induced morbidity/mortality / MGI
  • abnormal inflammatory response / MGI
  • abnormal dendritic cell physiology / MGI
  • increased susceptibility to viral infection / MGI
  • abnormal immunoglobulin level / MGI
  • abnormal cytokine secretion / MGI
  • corneal vascularization / MGI
  • increased susceptibility to viral infection induced morbidity/mortality / MGI
  • abnormal NK cell physiology / MGI
  • altered susceptibility to infection / MGI
  • immune system phenotype / MGI
  • abnormal CD8-positive, alpha-beta T cell physiology / MGI
  • abnormal interferon-gamma secretion / MGI
  • increased circulating interleukin-12 level / MGI
MGI phenotypes (gene matching)
  • decreased bone mineral density / MGI
  • increased leukocyte cell number / MGI
  • altered susceptibility to infection / MGI
  • abnormal inflammatory response / MGI
  • increased incidence of induced tumors / MGI
  • abnormal dendritic cell physiology / MGI
  • increased susceptibility to viral infection / MGI
  • abnormal macrophage physiology / MGI
  • abnormal immunoglobulin level / MGI
  • abnormal cytokine secretion / MGI
  • no phenotypic analysis / MGI
  • increased tumor growth/size / MGI
  • abnormal CD8-positive, alpha-beta T cell physiology / MGI
  • increased incidence of tumors by chemical induction / MGI
  • abnormal osteoclast morphology / MGI
  • abnormal response to infection / MGI
  • impaired natural killer cell mediated cytotoxicity / MGI
  • immune system phenotype / MGI
  • corneal vascularization / MGI
  • abnormal enzyme/coenzyme activity / MGI
  • decreased NK cell number / MGI
  • abnormal interferon-gamma secretion / MGI
  • decreased tumor necrosis factor secretion / MGI
  • decreased interferon-alpha secretion / MGI
  • decreased interferon-beta secretion / MGI
  • increased circulating interleukin-12 level / MGI
  • decreased interleukin-6 secretion / MGI
  • increased susceptibility to bacterial infection induced morbidity/mortality / MGI
  • increased susceptibility to viral infection induced morbidity/mortality / MGI
  • abnormal NK cell physiology / MGI

Literature references

  • Measles virus infection of SLAM (CD150) knockin mice reproduces tropism and immunosuppression in human infection.;Ohno Shinji, Ono Nobuyuki, Seki Fumio, Takeda Makoto, Kura Shinobu, Tsuzuki Teruhisa, Yanagi Yusuke, ;2007;Journal of virology;81;1650-9; 17135325

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).